lorviqua
pfizer europe ma eeig - lorlatinib - karcinoma, nesīkšūnu plaušas - antineoplastic agents, protein kinase inhibitors - lorviqua as monotherapy is indicated for the treatment of adult patients with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc) previously not treated with an alk inhibitor. lorviqua as monotherapy is indicated for the treatment of adult patients with alk‑positive advanced nsclc whose disease has progressed after:alectinib or ceritinib as the first alk tyrosine kinase inhibitor (tki) therapy; orcrizotinib and at least one other alk tki.
apredonav 5 mg apvalkotās tabletes
medochemie ltd., cyprus - ivabradīns - apvalkotā tablete - 5 mg
apredonav 7,5 mg apvalkotās tabletes
medochemie ltd., cyprus - ivabradīns - apvalkotā tablete - 7,5 mg
camcevi
accord healthcare s.l.u. - leuprorelin mesilate - prostatas audzēji - endokrīnā terapija - camcevi is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy.
enroxil flavour
krka, d.d., novo mesto, slovēnija - enrofloxacin - tabletes - 15 mg - kaķi; suņi
enroxil flavour
krka, d.d., novo mesto, slovēnija - enrofloxacin - tabletes - 50 mg - suņi
fromilid 250 mg apvalkotās tabletes
krka, d.d., novo mesto, slovenia - klaritromicīns - apvalkotā tablete - 250 mg
fromilid 125 mg/5 ml granulas iekšķīgi lietojamas suspensijas pagatavošanai
krka, d.d., novo mesto, slovenia - klaritromicīns - granulas iekšķīgi lietojamas suspensijas pagatavošanai - 125 mg/5 ml
fromilid 500 mg apvalkotās tabletes
krka, d.d., novo mesto, slovenia - klaritromicīns - apvalkotā tablete - 500 mg
fromilid uno 500 mg ilgstošās darbības tabletes
krka, d.d., novo mesto, slovenia - klaritromicīns - modificētās darbības tablete - 500 mg